lifestyle.childcarepartnerships.org

Author: argenx SE

argenx Brings Neuromuscular Leadership to AAN 2026 with New Data Supporting Broader VYVGART Use Across MG and CIDP

April 18, 2026
argenx announces Annual General Meeting of Shareholders on May 6, 2026

March 20, 2026